HomeLatest NewsCovid-19CDC’s Advisory Committee Recommends Approval of Pfizer’s COVID-19 Vaccine for Adolescents Age...

CDC’s Advisory Committee Recommends Approval of Pfizer’s COVID-19 Vaccine for Adolescents Age 12 and Older

On Wednesday, May 12, the CDC’s Advisory Committee on Immunization Practices (ACIP) recommended approval of the Pfizer COVID-19 vaccine for use in adolescents age 12 to 15. This followed the announcement on Monday, May 10, that the FDA had authorized the Pfizer vaccine for use in this age group.

We encourage you to make the Pfizer COVID-19 vaccine available to adolescents age 12 to 15 as soon as possible. In addition, we emphasize the CDC’s recommendation that COVID-19 and other vaccines may now be administered to everyone age 12 and up without regard to timing. This includes simultaneous administration of COVID-19 and other vaccines on the same day, as well as co-administration within 14 days.

With the decline in routine pediatric immunizations and well-child visits during the COVID-19 pandemic, we encourage health centers to help children and adolescents catch up on preventive care. Well-child visits are a good venue for routine and COVID-19 vaccinations, as well as a variety of important screenings and assessments.

Here are some key CDC resources related to this update:

Stay Connected

Unified Voice Newsletter

Events This Month

march

04marAll Day08Rev Cycle A-ZSDHFMA Event

05mar12:00 pm1:00 pmWrite with Purpose - Take back Hours by Writing BetterSDAHO Webinar

06mar1:00 pm2:00 pmPediatric Injury Prevention: From Bare Bones to Grandiose! It All HelpsDenver Health Trauma Webinar

07marAll DayMultidisciplinary Response to Victim Services Conference

07mar8:30 am11:45 amSpotlight Series for Healthcare ProvidersAvera Education


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact